
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded iontophoresis solution containing sodium chloride, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
FDA-approved products listing sodium chloride as the only active ingredient are injections, irrigation solutions and a solution for extracorporeal use. FDA-approved oral products contain it only in combination with polyethylene glycol and other salts, as powders for oral solution. Over-the-counter monograph products containing it are listed as oral tablets, nasal sprays and liquids, and eye drops and eye ointments.
This dose form is water-containing (aqueous). Under USP <795>, aqueous preparations carry shorter default beyond-use dates than nonaqueous ones, and a preservative in the base allows a longer date than no preservative. The date printed on the label is the one to follow.
Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.
Sodium chloride is an electrolyte replenisher used in injections, eye products and oral forms; compounded preparations require a prescription and are not FDA-approved.
Sodium chloride is the chemical name for salt and a source of sodium and chloride, the main electrolytes of the fluid outside the body's cells. Sodium helps control how water is distributed between body compartments. Manufactured products on DailyMed include sodium chloride injection (for example Baxter's, indicated as a source of water and electrolytes and, for the isotonic strength, as a hemodialysis priming solution), sodium chloride irrigation, Muro 128 hypertonic eye drops and ointment for temporary relief of corneal edema, saline nasal sprays, and sodium chloride tablets with a Drug Facts label for making an isotonic solution or as an electrolyte replenisher to prevent heat cramps from heavy sweating. A prescriber may order sodium chloride compounded as an oral liquid in a specific strength or in combination with other electrolytes. Compounded preparations are not FDA-approved and require a prescription.
The sodium chloride injection label has no boxed warning and lists no known contraindications. The label warns that allergic and infusion reactions, such as low blood pressure, fever, chills, hives, rash and itching, can occur. It also warns that too much fluid can cause swelling and fluid in the lungs, that sodium levels can become too high or too low, and that people with severe kidney disease, heart or lung failure, or conditions that cause sodium retention or edema are at higher risk. Corticosteroids can add to sodium and fluid retention, and diuretics and some seizure and psychiatric medicines raise the risk of low sodium. Sodium chloride can change lithium levels. The oral tablet label advises asking a doctor first if you follow a sodium-restricted diet, and asking a health professional if pregnant or breastfeeding. The injection label says its effects in pregnancy and on breast milk are not known. Muro 128 can cause temporary burning or irritation. For side effects, talk to your prescriber or pharmacist.
Sodium ions are the main electrolytes of extracellular fluid, and sodium and chloride are both regulated by the kidneys through tubular absorption and excretion; water distribution depends mainly on electrolyte concentrations across compartments (StatPearls). Isotonic saline expands intravascular volume without large fluid shifts; hypotonic and hypertonic concentrations exist for maintenance and specialized uses, and StatPearls notes saline is also given by nebulization in several strengths. Labeled indications: sodium chloride injection (Baxter) as a source of water and electrolytes, with the isotonic strength also a hemodialysis priming solution; Muro 128 (Bausch and Lomb) as an OTC hypertonicity agent for corneal edema. Per the injection label, use with drugs causing sodium and fluid retention (corticosteroids, corticotropin) raises the risk of hypernatremia and volume overload; diuretics, certain antiepileptics and psychotropics, and drugs increasing vasopressin effect raise hyponatremia risk; renal lithium clearance may change, so monitor lithium. Adverse reactions include hypersensitivity, hypernatremia, hyponatremia and hyperchloremic metabolic acidosis. Strength and dosing per prescriber. Monitor serum sodium and chloride, fluid balance, acid-base status, renal function and edema, particularly in heart failure, renal impairment and older or pediatric patients.
Iontophoresis is usually done by a physical therapist or other clinician, or at home only after training with the device. The clinician soaks the drug electrode with the solution, places the electrodes on the skin and runs the device for the set time, often about 20 minutes. Keep the bottle closed between sessions and bring it to each visit. Do not drink the solution.
Iontophoresis solutions are aqueous. Under USP <795>, a preserved solution usually carries a beyond-use date of up to 35 days at room temperature or refrigerated, and an unpreserved one 14 days refrigerated. Follow the storage line on your label, keep out of reach of children, and discard after the beyond-use date.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)